(Q36958262)

17 August 2017

1 reference

title

Renal calcium stones: insights from the control of bone mineralization (English)

1 reference

17 August 2017

Moochhala SH

1

1 reference

17 August 2017

Sayer JA

series ordinal

2

1 reference

17 August 2017

Carr G

series ordinal

3

1 reference

17 August 2017

Simmons NL

series ordinal

4

1 reference

17 August 2017

2 October 2007

1 reference

17 August 2017

Experimental Physiology

1 reference

17 August 2017

93

1 reference

17 August 2017

1

1 reference

17 August 2017

43-49

1 reference

Pyrophosphate inhibits mineralization of osteoblast cultures by binding to mineral, up-regulating osteopontin, and inhibiting alkaline phosphatase activity

17 August 2017

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.040790

Spondyloarthropathy: an independent risk factor for kidney stones

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.040790

Expression and localisation of the pyrophosphate transporter, ANK, in murine kidney cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.040790

High citrate diet delays progression of renal insufficiency in the ClC-5 knockout mouse model of Dent's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.040790

Synergism between the brushite and hydroxyapatite urinary crystallization inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.040790

Factors affecting the regrowth of renal stones in vitro: a contribution to the understanding of renal stone development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.040790

Randall's plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.040790

Randall's plaque: pathogenesis and role in calcium oxalate nephrolithiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.040790

Physiological and pathophysiological functions of the ecto-nucleotide pyrophosphatase/phosphodiesterase family

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.040790

Mineral formation in joints caused by complete or joint-specific loss of ANK function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.040790

Biochemical and genetic analysis of ANK in arthritis and bone disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.040790

Concerted regulation of inorganic pyrophosphate and osteopontin by akp2, enpp1, and ank: an integrated model of the pathogenesis of mineralization disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.040790

Role of the mouse ank gene in control of tissue calcification and arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.040790

Physiological functions of CLC Cl- channels gleaned from human genetic disease and mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.040790

The binding of pyrophosphate and two diphosphonates by hydroxyapatite crystals

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.040790

Determination of pyrophosphate in renal calculi and urine by means of an enzymatic method

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.040790

Heterozygous mutations in ANKH, the human ortholog of the mouse progressive ankylosis gene, result in craniometaphyseal dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.040790

Mutations in ANKH cause chondrocalcinosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.040790

Molecular modulation of calcium oxalate crystallization by osteopontin and citrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.040790

Pyrophosphate in synovial fluid and urine and its relationship to urinary risk factors for stone disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.040790

Metabolism of inorganic pyrophosphate (PPi)

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.040790

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.040790

Nephrocalcinosis: molecular insights into calcium precipitation within the kidney.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.040790

ANKH variants associated with ankylosing spondylitis: gender differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.040790

Proposed mechanisms in renal tubular crystal retention

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.040790

Renal osteopontin protein and mRNA upregulation during acute nephrotoxicity in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.040790

Investigation of the role ofANKHin ankylosing spondylitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.040790

10.1113/EXPPHYSIOL.2007.040790

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference